| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JCB.25571 |
| P698 | PubMed publication ID | 27070919 |
| P50 | author | Evelyne Doudnikoff | Q56441520 |
| Moin A Saleem | Q57265312 | ||
| Patrick Auguste | Q57323571 | ||
| Julien Villeneuve | Q87909524 | ||
| Christian Combe | Q41334325 | ||
| P2093 | author name string | Antoine Dewitte | |
| Jean Ripoche | |||
| Richard Daculsi | |||
| Claire Rigothier | |||
| Sébastien Lepreux | |||
| Chantal Bourget | |||
| P2860 | cites work | Cytokine balance in kidney tissue from lupus nephritis patients | Q53655942 |
| Immunological function of tubular epithelial cells: the functional implications of CD40 expression. | Q54519152 | ||
| Increased concentrations of soluble CD40 ligand may help to identify type 1 diabetic adolescents and young adults at risk for developing persistent microalbuminuria | Q57718046 | ||
| CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 | ||
| The CD40/CD154 receptor/ligand dyad | Q28202756 | ||
| Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes | Q28303199 | ||
| Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier | Q28512854 | ||
| CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury | Q30441065 | ||
| Molecular basis of glomerular permselectivity | Q34310480 | ||
| The glomerular basement membrane as a barrier to albumin | Q34351478 | ||
| Genetic kidney diseases disclose the pathogenesis of proteinuria | Q34454539 | ||
| Soluble CD40 ligand stimulates the pro-angiogenic function of peripheral blood angiogenic outgrowth cells via increased release of matrix metalloproteinase-9. | Q35073314 | ||
| Podocyte differentiation and hereditary proteinuria/nephrotic syndromes | Q35133217 | ||
| A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation | Q35379384 | ||
| Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventions | Q35621648 | ||
| T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation | Q35754623 | ||
| Role of matrix metalloproteinases in renal pathophysiologies | Q36693229 | ||
| Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy | Q37352123 | ||
| The role of CD40 and CD154/CD40L in dendritic cells | Q37518524 | ||
| The glomerular basement membrane | Q37992770 | ||
| Assembly and disassembly of cell matrix adhesions | Q38028168 | ||
| Cell-matrix adhesion of podocytes in physiology and disease | Q38075788 | ||
| One hundred ways to kill a podocyte | Q38338547 | ||
| Platelets in Glomerular Disease | Q40176963 | ||
| Renal tubular epithelial cells modulate T-cell responses via ICOS-L and B7-H1. | Q40362690 | ||
| Role of platelets in progressive glomerular diseases | Q40424212 | ||
| CD40 ligand increases complement C3 secretion by proximal tubular epithelial cells. | Q40426599 | ||
| Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes | Q40712590 | ||
| Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells | Q40941132 | ||
| Acquisition of CD40 expression during murine B-cell differentiation | Q41255045 | ||
| New frontiers for platelet CD154. | Q43182095 | ||
| Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells | Q44179199 | ||
| Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation | Q46046763 | ||
| Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40. | Q46749479 | ||
| Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria. | Q46910906 | ||
| Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus. | Q50862383 | ||
| Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? | Q52527039 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2737-2747 | |
| P577 | publication date | 2016-05-05 | |
| P1433 | published in | Journal of Cellular Biochemistry | Q6294917 |
| P1476 | title | CD154 Induces Matrix Metalloproteinase-9 Secretion in Human Podocytes | |
| P478 | volume | 117 |
| Q47164183 | LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin. |
| Q47153937 | Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS. |
| Q64943822 | Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus. |
| Q59799152 | Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury |
Search more.